Saratoga Health & Biotechnology Portfolio Fund Class A (SHPAX)

Fund Assets	12.04M
Expense Ratio	3.00%
Min. Investment	$250
Turnover	22.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Dec 9, 2025

Previous Close	25.21
YTD Return	18.57%
1-Year Return	23.88%
5-Year Return	45.15%
52-Week Low	20.50
52-Week High	25.88
Beta (5Y)	0.70
Holdings	29
Inception Date	Jul 15, 1999

About SHPAX

Saratoga Health & Biotechnology Portfolio Fund Class A is a mutual fund that primarily targets the health care and biotechnology sectors. The fund seeks long-term capital growth by investing at least 80% of its assets in equity securities of companies engaged in health care, pharmaceuticals, medical products, research, and biotechnology, both in the United States and internationally. Managed since 1999, it holds a diversified portfolio with approximately 32 holdings and notable concentrations in large-cap health care companies. Its top holdings include prominent industry names such as McKesson, Amgen, and Intuitive Surgical, reflecting a focus on market leaders within health innovation. The fund has an annual expense ratio of around 2.7% and requires a minimum initial investment of $250. With a strategy centered on growth in sectors driven by advances in medicine and technology, Saratoga Health & Biotechnology Portfolio Fund Class A plays a specialized role for investors seeking specific exposure to the evolving health and biotechnology industries.

• Fund Family: Saratoga
• Category: Health
• Performance Rating: Average
• Risk Rating: Below Average
• Stock Exchange: Nasdaq
• Ticker Symbol: SHPAX
• Share Class: Class A
• Index: S&P 500 TR

Performance

SHPAX had a total return of 23.88% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.82%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FACDX	Fidelity	Fidelity Advisor Health Care A	0.92%
FACTX	Fidelity	Fidelity Advisor Health Care M	1.23%
FBIOX	Fidelity	Fidelity Select Biotechnology Portfolio	0.60%
FBTAX	Fidelity	Fidelity Advisor Biotechnology A	0.95%
FBTCX	Fidelity	Fidelity Advisor Biotechnology C	1.65%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
SBHIX	Class I	2.60%
SHPCX	Health & Biotechnology Porfolio Class C	3.60%

Top 10 Holdings

50.39% of assets

Name	Symbol	Weight
Amgen Inc.	AMGN	5.93%
Jazz Pharmaceuticals plc	JAZZ	5.69%
United Therapeutics Corporation	UTHR	5.64%
McKesson Corporation	MCK	5.29%
Cardinal Health, Inc.	CAH	5.05%
Exelixis, Inc.	EXEL	4.95%
Regeneron Pharmaceuticals, Inc.	REGN	4.56%
Cencora, Inc.	COR	4.53%
Medpace Holdings, Inc.	MEDP	4.42%
Johnson & Johnson	JNJ	4.32%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 9, 2025	$0.7788	Dec 10, 2025
Dec 10, 2024	$0.2534	Dec 11, 2024
Dec 8, 2023	$1.0202	Dec 11, 2023
Dec 9, 2022	$1.2749	Dec 12, 2022
Dec 10, 2021	$0.7883	Dec 13, 2021
Dec 11, 2020	$2.5794	Dec 11, 2020

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Nov 9, 2026

Data Sources Report a data error